Proof of Confidence Study of CCR2 Antagonist (BMS-741672) in Insulin Resistance

Clinical trial NCT00699790 · COMPLETED

Trial details

NCT number: NCT00699790
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2009-02-01
Primary completion: 2009-12-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.